BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35780638)

  • 1. The expression and prognostic significance of PIK3CB in lung adenocarcinoma.
    Che N; Zhao N; Zhao X; Su S; Zhang Y; Bai X; Li F; Zhang D; Li Y
    Ann Diagn Pathol; 2022 Oct; 60():152001. PubMed ID: 35780638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CB promotes oesophageal cancer proliferation through the PI3K/AKT/mTOR signalling axis.
    Xu W; Wang Z; Zhang Z; Xu J; Jiang Y
    Cell Biol Int; 2022 Sep; 46(9):1399-1408. PubMed ID: 35842767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis.
    Zhang M; Liang Y; Song P
    J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma.
    Ying J; Hong H; Yu C; Jiang M; Ding D
    Medicine (Baltimore); 2023 Sep; 102(38):e34954. PubMed ID: 37746997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SSBP1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Huang J; Xie ZF
    Math Biosci Eng; 2022 Jan; 19(3):3022-3035. PubMed ID: 35240818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
    Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
    World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction.
    Zuo B; Wang L; Li X; Li X; Wang J; Xiong Y; Lei J; Zhang X; Chen Y; Liu Q; Jiao J; Sui M; Fan J; Wu N; Song Z; Li G
    Aging (Albany NY); 2023 Nov; 15(21):12451-12475. PubMed ID: 37955668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
    Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
    Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.